Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo
In vitro and in vivo activities against Trypanosoma cruzi were evaluated for two sesquiterpene lactones: psilostachyin A and cynaropicrin. Cynaropicrin had previously been shown to potently inhibit African trypanosomes in vivo, and psilostachyin A had been reported to show in vivo effects against T. cruzi, albeit in another test design. In vitro data showed that cynaropicrin was more effective than psilostachyin A. Ultrastructural alterations induced by cynaropicrin included shedding events, detachment of large portions of the plasma membrane, and vesicular bodies and large vacuoles containing membranous structures, suggestive of parasite autophagy. Acute toxicity studies showed that one of two mice died at a cynaropicrin dose of 400 mg/kg of body weight given intraperitoneally (i.p.). Although no major plasma biochemical alterations could be detected, histopathology demonstrated that the liver was the most affected organ in cynaropicrin-treated animals. Although cynaropicrin was as effective as benznidazole against trypomastigotes in vitro, the treatment (once or twice a day) of T. cruzi-infected mice (up to 50 mg/kg/day cynaropicrin) did not suppress parasitemia or protect against mortality induced by the Y and Colombiana strains. Psilostachyin A (0.5 to 50 mg/kg/day given once a day) was not effective in the acute model of T. cruzi infection (Y strain), reaching 100% animal mortality. Our data demonstrate that although it is very promising against African trypanosomes, cynaropicrin does not show efficacy compared to benznidazole in acute mouse models of T. cruzi infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Antimicrobial agents and chemotherapy - 57(2013), 11 vom: 23. Nov., Seite 5307-14 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
da Silva, Cristiane França [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Benzonidazole |
|---|
| Anmerkungen: |
Date Completed 14.05.2014 Date Revised 21.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1128/AAC.00595-13 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM229977006 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM229977006 | ||
| 003 | DE-627 | ||
| 005 | 20231224083337.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/AAC.00595-13 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0766.xml |
| 035 | |a (DE-627)NLM229977006 | ||
| 035 | |a (NLM)23939901 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a da Silva, Cristiane França |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2014 | ||
| 500 | |a Date Revised 21.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In vitro and in vivo activities against Trypanosoma cruzi were evaluated for two sesquiterpene lactones: psilostachyin A and cynaropicrin. Cynaropicrin had previously been shown to potently inhibit African trypanosomes in vivo, and psilostachyin A had been reported to show in vivo effects against T. cruzi, albeit in another test design. In vitro data showed that cynaropicrin was more effective than psilostachyin A. Ultrastructural alterations induced by cynaropicrin included shedding events, detachment of large portions of the plasma membrane, and vesicular bodies and large vacuoles containing membranous structures, suggestive of parasite autophagy. Acute toxicity studies showed that one of two mice died at a cynaropicrin dose of 400 mg/kg of body weight given intraperitoneally (i.p.). Although no major plasma biochemical alterations could be detected, histopathology demonstrated that the liver was the most affected organ in cynaropicrin-treated animals. Although cynaropicrin was as effective as benznidazole against trypomastigotes in vitro, the treatment (once or twice a day) of T. cruzi-infected mice (up to 50 mg/kg/day cynaropicrin) did not suppress parasitemia or protect against mortality induced by the Y and Colombiana strains. Psilostachyin A (0.5 to 50 mg/kg/day given once a day) was not effective in the acute model of T. cruzi infection (Y strain), reaching 100% animal mortality. Our data demonstrate that although it is very promising against African trypanosomes, cynaropicrin does not show efficacy compared to benznidazole in acute mouse models of T. cruzi infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Lactones |2 NLM | |
| 650 | 7 | |a Nitroimidazoles |2 NLM | |
| 650 | 7 | |a Sesquiterpenes |2 NLM | |
| 650 | 7 | |a Trypanocidal Agents |2 NLM | |
| 650 | 7 | |a psilostachyin A |2 NLM | |
| 650 | 7 | |a cynaropicrin |2 NLM | |
| 650 | 7 | |a M9233789I9 |2 NLM | |
| 650 | 7 | |a benzonidazole |2 NLM | |
| 650 | 7 | |a YC42NRJ1ZD |2 NLM | |
| 700 | 1 | |a Batista, Denise da Gama Jaen |e verfasserin |4 aut | |
| 700 | 1 | |a De Araújo, Julianna Siciliano |e verfasserin |4 aut | |
| 700 | 1 | |a Batista, Marcos Meuser |e verfasserin |4 aut | |
| 700 | 1 | |a Lionel, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a de Souza, Elen Mello |e verfasserin |4 aut | |
| 700 | 1 | |a Hammer, Erica Ripoll |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva, Patricia Bernardino |e verfasserin |4 aut | |
| 700 | 1 | |a De Mieri, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Adams, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Zimmermann, Stefanie |e verfasserin |4 aut | |
| 700 | 1 | |a Hamburger, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Brun, Reto |e verfasserin |4 aut | |
| 700 | 1 | |a Schühly, Wolfgang |e verfasserin |4 aut | |
| 700 | 1 | |a Soeiro, Maria de Nazaré Correia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antimicrobial agents and chemotherapy |d 1972 |g 57(2013), 11 vom: 23. Nov., Seite 5307-14 |w (DE-627)NLM000026506 |x 1098-6596 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2013 |g number:11 |g day:23 |g month:11 |g pages:5307-14 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/AAC.00595-13 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2013 |e 11 |b 23 |c 11 |h 5307-14 | ||